FDA Import Refusal SCS-0488010-4/21/4 — Ipca Laboratories Limited
The FDA refused shipment SCS-0488010-4/21/4 from Ipca Laboratories Limited (India) on October 22, 2023. The refused product falls under Drugs and Biologics — METHOTREXATE (ANTI-NEOPLASTIC). Cited charge: 27 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- October 22, 2023
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62ICA31 METHOTREXATE (ANTI-NEOPLASTIC)
- Charges
- 27